| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b787ed6b2bb37df983cad8522fd7408 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4433 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 |
| filingDate |
2016-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f721d1abd1f2bfba42301d60de0f19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38145c6e4a63dcb230b9fc130f4f3fad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad9e13d64f59409dcd561f09186fafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e862e629f5643a20ba430ad2e53807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9654964c762cb7a64066e90117b50e84 |
| publicationDate |
2018-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018256580-A1 |
| titleOfInvention |
Combination therapies for treatment of cancer |
| abstract |
Combination therapies for treatment of cancer are provided. The disclosed methods comprise administration of a cyclin-dependent kinase inhibitor and a DNA methyltransferase inhibitor to a mammal in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10624880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10422788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562925-B2 |
| priorityDate |
2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |